With respect to assay development, quality assurance and, ultimately, clinical adoption, the primary subject of this review, these advantages are critical. Implicit with these advantages, TMAs enable ...
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...
Researchers from Lund University (Sweden) have investigated the tumor immune microenvironment of primary triple-negative breast cancer using digital image analysis of IHC-stained immune cells. To do ...
Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial. Continuous MMAI scores ...
6don MSN
Biological shield can prevent skin cancer cells from transforming into aggressive metastatic forms
A new study has identified a molecular guardian that keeps skin cells from forgetting what they are and transforming into aggressive, migratory killers. By stabilizing a master genetic switch, this ...
This system used a cGAN architecture to design a virtual mIHC staining model that rapidly transforms label-free AF images (DAPI, FITC, TxRed, and Cy5) of tissue samples into their corresponding BF ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results